Harvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  2. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence

    Molecular Psychiatry, Vol. 28, Núm. 1, pp. 354-368

  3. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics

    World Psychiatry, Vol. 21, Núm. 2, pp. 168-188

  5. Virtual Ontogeny of Cortical Growth Preceding Mental Illness

    Biological Psychiatry, Vol. 92, Núm. 4, pp. 299-313

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

    Schizophrenia Research, Vol. 227, pp. 10-17

  3. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63

2020

  1. Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study

    Molecular Psychiatry, Vol. 25, Núm. 11, pp. 2818-2831

  2. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA

    NeuroImage, Vol. 218

  3. Publisher Correction: Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder (Nature Neuroscience, (2017), 20, 9, (1217-1224), 10.1038/nn.4598)

    Nature Neuroscience

2018

  1. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: Results from the ENIGMA Schizophrenia DTI Working Group

    Molecular Psychiatry, Vol. 23, Núm. 5, pp. 1261-1269

2017

  1. Individual differences in the dominance of interhemispheric connections predict cognitive ability beyond sex and brain size

    NeuroImage, Vol. 155, pp. 234-244

  2. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder

    Nature Neuroscience, Vol. 20, Núm. 9, pp. 1217-1224

2012

  1. Cortical structural abnormalities in deficit versus nondeficit schizophrenia

    Schizophrenia Research, Vol. 136, Núm. 1-3, pp. 51-54